China Health Group Ltd (HK:0673)
:0673
Want to see HK:0673 full AI Analyst Report?
0673 Stock Chart & Stats
HK$0.76
HK$0.03(9.09%)
At close: 4:00 PM EST
HK$0.76
HK$0.03(9.09%)
Day’s Range― - ―
52-Week RangeHK$0.11 - HK$0.86
Previous CloseN/A
Volume864.00K
Average Volume (3M)617.89K
Market Cap
HK$721.31M
Enterprise ValueHK$195.88M
Total Cash (Recent Filing)HK$1.05M
Total Debt (Recent Filing)HK$6.50M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,387,138,200
10 Day Avg. Volume474,015
30 Day Avg. Volume617,889
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-14.98
Price to Sales (P/S)2.95
P/FCF Ratio-13.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Healthcare Business ModelChina Health Group's diversified healthcare model — hospital investments, management services and healthcare technology — creates multiple durable revenue channels tied to structural healthcare demand. This mix supports recurring management fees and project income, helping stabilize revenues over the medium term if operations are maintained.
Modest Reported LeverageReported total debt of roughly HK$6.5m is low in absolute terms, limiting interest expense and near-term refinancing pressure. Lower leverage provides financial flexibility to pursue restructuring, negotiate with creditors, or raise corrective capital, which helps absorb shocks while executing a multi-month turnaround.
Stable Gross MarginsRelatively steady gross margins in the low-to-mid 20% range indicate the core service pricing and direct-cost base remain intact. This margin resilience means profitability can return if the company reduces operating expenses or regains scale, making margins a durable lever for recovery over several months.
Bears Say
Multi-year Revenue DeclineThree consecutive years of revenue decline, including a ~19% YoY drop in the latest year, signals persistent loss of scale or demand. Shrinking top line undermines operating leverage, stresses fixed-cost recovery and makes sustainable margins and free cash flow restoration much harder without clear strategic initiatives to reverse the trend.
Severely Negative ProfitabilityMargins plunging to roughly -170% reflect a cost structure far outstripped by current revenue. Such deep losses rapidly erode capital, limit the ability to invest in growth or quality improvements, and increase dependency on external financing or asset sales to sustain operations over the medium term.
Negative Equity And Recurring Cash BurnEquity turning negative combined with recurring operating and free cash flow deficits (~-HK$6.8m and -HK$8.4m) materially raises solvency and refinancing risk. Negative net worth constrains capital-raising options and increases probability of dilution or distress financing unless cash burn is quickly arrested or new capital is secured.
China Health Group News
0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.11 and its highest was HK$0.86 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$721.31M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Jun 25, 2026 which is in 56 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Nov 28, 2025. The company reported -HK$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.021.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 1,387,138,200 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.70%
12-Months-Change
Fundamentals
Return on Equity
476.63%
Trailing 12-Months
Asset Growth
7.65%
Trailing 12-Months
Company Description
China Health Group Ltd
China Health Group (0673) is a healthcare-focused company operating primarily in China. The company is engaged in various sectors including pharmaceuticals, health supplements, and medical services. It aims to improve health outcomes through the provision of high-quality healthcare products and services, catering to the growing demand for health solutions in the region.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―